loadpatents
name:-0.015729904174805
name:-0.0093369483947754
name:-0.001978874206543
Cadieux; Jean-Jacques Patent Filings

Cadieux; Jean-Jacques

Patent Applications and Registrations

Patent applications and USPTO patent grants for Cadieux; Jean-Jacques.The latest application filed is for "enantiomers of spiro-oxindole compounds and their uses as therapeutic agents".

Company Profile
0.11.15
  • Cadieux; Jean-Jacques - Burnaby CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Enantiomers of spiro-oxindole compounds and their uses as therapeutic agents
Grant 8,883,840 - Chafeev , et al. November 11, 2
2014-11-11
Synthetic methods for spiro-oxindole compounds
Grant 8,742,109 - Cadieux , et al. June 3, 2
2014-06-03
Enantiomers of spiro-oxindole compounds and their uses as therapeutic agents
Grant 8,450,358 - Chafeev , et al. May 28, 2
2013-05-28
Synthetic methods for spiro-oxindole compounds
Grant 8,445,696 - Cadieux , et al. May 21, 2
2013-05-21
Spiro-oxindole compounds and their uses as therapeutic agents
Grant 8,415,370 - Chafeev , et al. April 9, 2
2013-04-09
Synthetic Methods For Spiro-oxindole Compounds
App 20130072686 - Cadieux; Jean-Jacques ;   et al.
2013-03-21
Enantiomers Of Spiro-oxindole Compounds And Their Uses As Therapeutic Agents
App 20130072537 - Chafeev; Mikhail ;   et al.
2013-03-21
Spiro-oxindole Compounds And Their Uses As Therapeutic Agents
App 20120295897 - Chafeev; Mikhail ;   et al.
2012-11-22
Spiro-oxindole compounds and their use as therapeutic agents
Grant 8,263,606 - Chafeev , et al. September 11, 2
2012-09-11
Spiro (furo [3, 2-c] Pyridine-3-3' -indol) -2' (1'h)-one Derivatives And Related Compounds For The Treatment Of Sodium-channel Mediated Diseases, Such As Pain
App 20110294842 - Cadieux; Jean-Jacques ;   et al.
2011-12-01
Spiro-oxindole-derivatives As Sodium Channel Blockers
App 20110269788 - Cadieux; Jean-Jacques ;   et al.
2011-11-03
Synthetic Methods For Spiro-oxindole Compounds
App 20110087027 - Cadieux; Jean-Jacques ;   et al.
2011-04-14
Enantiomers Of Spiro-oxindole Compounds And Their Uses As Therapeutic Agents
App 20100331386 - Chafeev; Mikhail ;   et al.
2010-12-30
Aromatic And Heteroaromatic Compounds Useful In Treating Iron Disorders
App 20100240713 - Cadieux; Jean-Jacques ;   et al.
2010-09-23
Spiro (furo [3, 2-c] Pyridine-3-3' -indol) -2' (1'h)-one Derivatives And Related Compounds For The Treatment Of Sodium-channel Mediated Diseases, Such As Pain
App 20100160362 - Cadieux; Jean-Jacques ;   et al.
2010-06-24
Spiro-oxindole Compounds And Their Use As Therapeutic Agents
App 20100137299 - Chafeev; Mikhail ;   et al.
2010-06-03
Tricyclic Compounds Useful In Treating Iron Disorders
App 20090069408 - Chafeev; Mikhail ;   et al.
2009-03-12
Biaryl And Biheteroaryl Compounds Useful In Treating Iron Disorders
App 20080234384 - Chafeev; Mikhail ;   et al.
2008-09-25
Dihydroindazole Compounds Useful In Treating Iron Disorders
App 20080234327 - Cadieux; Jean-Jacques ;   et al.
2008-09-25

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed